Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium diquafosol vs sodium hyaluronate for dry eye induced by orthokeratology lenses
ChiCTR2600117838Phase 4Not yet recruiting
- Sponsor
- Hebei Eye Hospital
- Start
- Jan 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in dry eye syndrome (DED) comparing Sodium diquafosol arm with Sodium hyaluronate arm (2 arms). Primary endpoint: Non-invasive tear film break-up time at 3 months. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
diquafosol sodiumsodium hyaluronate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2600117838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117838.